时间控制适应性通气预防与治疗急性肺损伤:基于生理学的气道压力释放通气改良
急性呼吸窘迫综合征(ARDS)死亡率仍高约39%,机械通气是主要支持治疗,但设置不当可增加死亡风险。近期研究提示通气诱导肺损伤(VILI)由区域性肺应变过大所致,尤其见于存在潮汐性复张/去复张和应力倍增的肺泡不稳定区域。时间控制适应性通气(TCAV)方法基于开放与塌陷时间常数,利用气道压力释放通气(APRV)模式,通过延长吸气时间逐步使肺泡和肺泡管开放、用亚秒级呼气时间防止肺泡塌陷,并根据前一次呼吸调整下一次呼吸以实现实时滴定。本综述描述TCAV方法对病理生理的影响及其对急性肺损伤或高危肺的保护作用。
要点
- ARDS死亡率仍高约39%,机械通气是少数支持治疗之一,但设置不当可进一步增加死亡风险。
- VILI由区域性肺应变过大引起,尤其见于肺泡不稳定区域发生潮汐性复张/去复张和应力倍增。
- TCAV利用APRV模式,基于开放与塌陷时间常数,用延长吸气时间逐步使肺泡和肺泡管开放。
- TCAV用亚秒级呼气时间防止肺泡塌陷,并根据前一次呼吸配置下一次呼吸,实现实时滴定。
- 转化动物ARDS模型显示TCAV可减少VILI,外科/创伤患者中显示可降低死亡率。
适用人群与场景
- 患有急性肺损伤或处于急性肺损伤高风险的患者。
- 转化动物ARDS模型。
- 外科/创伤患者。
处置流程与药物剂量
- TCAV使用气道压力释放通气(APRV)模式,基于开放和塌陷时间常数调整通气。
- 用延长的吸气时间逐步使肺泡和肺泡管开放。
- 用亚秒级(不足1秒)的呼气时间防止肺泡塌陷,该时间不足以让肺泡塌陷。
- 根据前一次呼吸配置每一次呼吸,实现通气设置的实时滴定。
研究设计与关键结果
- ARDS死亡率仍高约39%。
- 近期研究提示VILI由区域性肺应变过大引起,尤其见于肺泡不稳定区域发生潮汐性复张/去复张和应力倍增。
- TCAV方法在转化动物ARDS模型中可减少VILI,在外科/创伤患者中可降低死亡率。
- TCAV通过延长吸气时间和亚秒级呼气时间实现开放且稳定的肺,减少区域应变并增加肺保护。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为TCAV方法将机械通气从任意设置转变为个性化和适应性设置。
- 作者认为TCAV可减少区域应变并提供更大肺保护。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Mortality in acute respiratory distress syndrome (ARDS) remains unacceptably high at approximately 39%. One of the only treatments is supportive: mechanical ventilation. However, improperly set mechanical ventilation can further increase the risk of death in patients with ARDS. Recent studies suggest that ventilation-induced lung injury (VILI) is caused by exaggerated regional lung strain, particularly in areas of alveolar instability subject to tidal recruitment/derecruitment and stress-multiplication. Thus, it is reasonable to expect that if a ventilation strategy can maintain stable lung inflation and homogeneity, regional dynamic strain would be reduced and VILI attenuated. A time-controlled adaptive ventilation (TCAV) method was developed to minimize dynamic alveolar strain by adjusting the delivered breath according to the mechanical characteristics of the lung. The goal of this review is to describe how the TCAV method impacts pathophysiology and protects lungs with, or at high risk of, acute lung injury. We present work from our group and others that identifies novel mechanisms of VILI in the alveolar microenvironment and demonstrates that the TCAV method can reduce VILI in translational animal ARDS models and mortality in surgical/trauma patients. Our TCAV method utilizes the airway pressure release ventilation (APRV) mode and is based on opening and collapsing time constants, which reflect the viscoelastic properties of the terminal airspaces. Time-controlled adaptive ventilation uses inspiratory and expiratory time to (1) gradually "nudge" alveoli and alveolar ducts open with an extended inspiratory duration and (2) prevent alveolar collapse using a brief (sub-second) expiratory duration that does not allow time for alveolar collapse. The new paradigm in TCAV is configuring each breath guided by the previous one, which achieves real-time titration of ventilator settings and minimizes instability induced tissue damage. This novel methodology changes the current approach to mechanical ventilation, from arbitrary to personalized and adaptive. The outcome of this approach is an open and stable lung with reduced regional strain and greater lung protection.
参考来源
- Nieman GF, Gatto LA, Andrews P, et al. Prevention and treatment of acute lung injury with time-controlled adaptive ventilation: physiologically informed modification of airway pressure release ventilation. Ann Intensive Care. 2020. PMID: 31907704. doi:10.1186/s13613-019-0619-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。